Our latest research in Cellular and Molecular Life Sciences! We explore how Syndecan-3 (SDC3) influences macrophage behavior within the TME.
https://t.co/WYLje8lLI9
#Immunotherapy#CancerResearch#Macrophages#Syndecan3
@outremer511 Interesting angle. If this is the case, the ADC should still be able to reach the tumor even when bound to plasma EDB and release the payload after cathepsin cleavage
1/13 In our new @CD_AACR paper we report an improved strategy to apply immunotherapy to brain metastasis, specially to those that are symptomatic, which has been reported to poorly respond to immune checkpoint blockade antibodies. https://t.co/d5kHSydKPW
PhD-efeated! 🎉 Happy to announce I defended my thesis on July 11th. Heartfelt thanks to the AP lab, and the committee @SanchoLab, @ArkaitzLab, and @Casanova_Acebes for your invaluable insights. Honored to discuss my work with experts I look up to. 🔬
👤@asispalazon
🏛️@CICBIOGUNE
👥 Yesterday, we met with @alena_grosvidal (@VHIO), @asispalazon (@CICbioGUNE), and team members at the annual meeting of our @FundlaCaixa project! 🔬 For over 3 years, we've been working on the development of enabling technologies for T-cell immunotherapy of solid tumors 🧬
Brillant talk by Borja Jiménez Lasheras from @asispalazon@CICbioGUNE at #MWC2024 Harald von Boehmer Midwinter Conference on Neddlytation on CD8 T cells 👏🏔️ very big work and presentation!
El Dr. Asís Palazón investiga en @CICbioGUNE en torno al desarrollo de terapias celulares innovadoras para el tratamiento del cáncer. 🔬
Esta investigación cuenta con el apoyo de @ContraCancerEs y Asociación Contra el Cáncer Bizkaia ✨
https://t.co/Vz5Kj8uHQP
🛑SAVE THE DATE!
3rd ASEICA ASPIC International Meeting: Cancer Immunology, Tumor Microenvironment and Metastasis
📅October 26th & 27th 2023
🏙️Porto
📘https://t.co/QZ1O9UOrIZ
✅You may join ASEICA or @ASPICancro before registration and benefit from the discounted rate
New (and sweet) partner in town!!
In our last work we determined the crystal structure of Siglec-15 checkpoint and identified CD11b as a glycan-dependent binding partner on T cells
Read full #glycotime story at @NatureComms here ⬇️⬇️
https://t.co/tn1ylZPcxm